TMCnet News
Ambrosia launches revolutionary "Direct-to-Apple Watch" NightRider BluCon for Continuous Glucose MonitoringSAN FRANCISCO, July 19, 2019 /PRNewswire/ -- Ambrosia Systems, a fast growing medical technology company, today announced the launch of the next version of NightRider BluCon. The new NightRider BluCon works with Apple watch to display glucose readings from the FreeStyle Libre and Libre Pro sensors on Apple watch without the phone. This will help parents of the millions of Type 1 diabetic children monitor their children's glucose levels when the child is away. Currently, parents don't have a way to know the current glucose levels of their Type 1 diabetic child if he or she is not carrying their phone, which most schools don't allow. Also, it is difficult for young children to carry their phone all the time. After Disclaimer: Ambrosia apps are not FDA approved and should not be used to make medical decisions. About Ambrosia Systems Ambrosia Systems is a fast growing medical technology company focused on building easy to use and affordable technology solutions for patients, providers, payers and caregivers. The NightRider BluCon is currently in use in more than 100 countries with FreeStyle Libre, FreeStyle Libre 2 and FreeStyle Libre Pro sensors. To learn more, visit www.ambrosiasys.com Media Contacts: Mia Flaherty, Ambrosia Systems Inc. [email protected], +1-415-293-8242 View original content to download multimedia:http://www.prnewswire.com/news-releases/ambrosia-launches-revolutionary-direct-to-apple-watch-nightrider-blucon-for-continuous-glucose-monitoring-300887904.html SOURCE Ambrosia Systems |